New cell therapy aims to tame lupus kidney flares
NCT ID NCT07570862
First seen May 07, 2026 · Last updated May 07, 2026
Summary
This study tests a treatment called FT819 for people with severe lupus that has caused kidney inflammation (lupus nephritis) and hasn't improved with other treatments. FT819 uses specially engineered immune cells to target and calm the overactive immune system. The main goal is to see if the treatment can restore normal kidney function by 26 weeks. About 53 participants aged 12 to 70 will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Conditions
Explore the condition pages connected to this study.